Mounjaro® injection (tirzepatide)

Mounjaro online: doses, cost and the savings card, explained

The FDA approved Mounjaro to treat type 2 diabetes. It is not approved for weight loss. A licensed Zealthy provider can review your health history online, then advise whether Mounjaro, Zepbound® or something else suits you.

  • One injection a week of tirzepatide, which acts on GIP and GLP-1 receptors
  • When your plan covers brand Mounjaro, the copay can be as low as $25/mo*
  • Intake reviewed online. No live appointment needed to start
  • Open to eligible adults in all 50 states
Hand holding a phone that shows a Zealthy intake question about weight loss goals
Start with a short online intake
Phone screen showing a smiling provider in a white coat with a stethoscope
Reviewed by a U.S.-licensed provider
Zealthy compounded tirzepatide vial with a green label. It is not Mounjaro
Zealthy compounded tirzepatide. Not Mounjaro, not FDA-approved†
$25/moBrand Mounjaro copay can be this low when your plan covers it*
$216/moCompounded tirzepatide, 3-month supply. Not Mounjaro†
$39Zealthy membership, first month
Is Mounjaro approved for weight loss?

No. The FDA approved Mounjaro in May 2022 for blood sugar control in type 2 diabetes.1 Weight management is not on its label. The tirzepatide product approved for that is Zepbound.

What are the Mounjaro doses?

Six strengths: 2.5, 5, 7.5, 10, 12.5 and 15 mg, injected once a week. You start at 2.5 mg, and the dose rises only when your blood sugar calls for it.2 See the dose schedule.

Who can use the Mounjaro savings card?

People with commercial insurance and a prescription for an approved use, meaning type 2 diabetes. Government insurance is excluded.3 See the savings card rules.

*Copays are set by your plan, and coverage is not guaranteed. $25 is the lowest price under Eli Lilly’s Mounjaro Savings Card, which requires covered commercial insurance and an on-label prescription. Active Zealthy membership required. †$329 a month, or from $216 a month on a 3-month supply. No compounded medication is FDA-approved, and the FDA does not review these products for safety, effectiveness or quality. Membership ($39 in month one, $135 monthly after) is separate.

Safety summary: Mounjaro carries a boxed warning about possible thyroid tumors. It is not for anyone whose own or family history includes medullary thyroid carcinoma, or for people with Multiple Endocrine Neoplasia syndrome type 2. Read the full safety information.

In a 72-week trial, adults with type 2 diabetes lost an average of 14.7% of their weight on tirzepatide 15 mg

The trial, SURMOUNT-2, gave 938 adults with type 2 diabetes and a BMI of 27 or higher weekly tirzepatide 10 mg, 15 mg or placebo. After 72 weeks, people had lost 12.8% of their weight on average with 10 mg, 14.7% with 15 mg and 3.2% with placebo.4 Mounjaro is the same drug, approved for blood sugar: in a 40-week study, A1C fell by 2.0 to 2.3 points.2

Pounds lost at the trial’s
14.7% average on 15 mg
37lbs

At the 10 mg and 15 mg averages: 32 to 37 lbs

This is arithmetic on one trial’s averages, not a forecast for you. Everyone in the trial had type 2 diabetes and received diet and activity counseling, and results varied.5 Mounjaro is not approved for weight loss.

What Mounjaro is, and how it differs from Zepbound

Mounjaro is Eli Lilly’s weekly tirzepatide injection for type 2 diabetes. Zepbound is the same drug approved for weight management. Compounded tirzepatide is neither.

FeatureBrand MounjaroThe diabetes labelBrand ZepboundThe weight management labelCompounded tirzepatideNot a brand product
Active ingredientTirzepatideTirzepatideTirzepatide, made by a compounding pharmacy
FDA-approved forType 2 diabetes from age 10, and cardiovascular risk in adults with type 2 diabetes2Weight reduction in adults, and sleep apnea in adults who have obesity5Not FDA-approved. The FDA does not review it for safety, effectiveness or quality6
Approved for weight lossNoYesNo
Where it is filledYour own pharmacyYour own pharmacyShipped from a partner pharmacy
Medication cost through ZealthyPlan copay, as low as $25/mo when coveredPlan copay, as low as $25/mo when covered$329/mo, or from $216/mo on a 3-month supply
Zealthy membership$39 in month one, then $135 monthly. Medication not included.

How Mounjaro works

Tirzepatide is a single molecule that activates two receptors, GIP and GLP-1. It prompts the pancreas to release insulin when blood sugar is high, lowers the hormone glucagon, slows stomach emptying and reduces how much people eat. Its half-life of about five days is what allows once-weekly dosing.2

Mounjaro vs Zepbound: one drug, two labels

Each is Eli Lilly’s tirzepatide, sold in six identical strengths under an identical boxed warning. The differences are the approved uses, the dosing rules, the savings cards and the prices. Zepbound’s label requires a step up to at least 5 mg, while Mounjaro’s raises the dose only as blood sugar requires.5 Our Zepbound page covers the weight management side.

Mounjaro for weight loss, in short

  • People in Mounjaro’s diabetes trials lost weight, but the FDA has not approved it for that purpose. Prescribing it for weight loss alone is off-label.2
  • Plans have generally covered GLP-1 drugs for diabetes. In KFF’s 2026 survey, 18% of employers with 200 or more workers covered them mainly for weight loss.7
  • The savings card from Lilly only applies to on-label prescriptions.3
  • Without type 2 diabetes, expect your provider to discuss Zepbound first.

Mounjaro trial results for blood sugar, weight and the heart

In its main trials Mounjaro lowered A1C by about 1.7 to 2.4 points and reduced weight at every dose. Eli Lilly funded all of them.

TrialWho was studiedCompared withResult on tirzepatide
SURPASS-1478 adults with type 2 diabetes on no other diabetes drug, 40 weeksPlaceboA1C down 1.7 to 1.8 points (placebo 0.1). Weight down 6.3 to 7.8 kg (placebo 1.0 kg).2
SURPASS-21,879 adults on metformin, 40 weeksSemaglutide 1 mg, the drug in Ozempic®A1C down 2.0 to 2.3 points (semaglutide 1.9). Weight down 7.6 to 11.2 kg (semaglutide 5.7 kg).8
SURPASS-5475 adults on basal insulin, 40 weeksPlaceboA1C down 2.1 to 2.4 points (placebo 0.9). Weight down 5.4 to 8.8 kg (placebo gained 1.6 kg).2
SURMOUNT-2938 adults with type 2 diabetes and a BMI of 27 or more, 72 weeksPlaceboWeight down 12.8% (10 mg) and 14.7% (15 mg), against 3.2% for placebo.4
SURPASS-CVOT13,299 adults with type 2 diabetes and cardiovascular disease, about four yearsDulaglutide 1.5 mgCardiovascular death, heart attack or stroke in 12.2% versus 13.1%. Tirzepatide was no worse, but not proven better.9

A1C is the blood sugar measure used in diabetes trials. Figures are average changes from the start of each trial. Individual results vary.

Mounjaro weight loss results in context

In Mounjaro’s diabetes trials, average weight loss ranged from 5.4 to 11.3 kg (about 12 to 25 lb), depending on dose and study.2 The larger percentages quoted for tirzepatide come from people without diabetes: 15.0% to 20.9% over 72 weeks in SURMOUNT-1, against 3.1% on placebo.10 For the comparison with semaglutide, see Mounjaro vs Ozempic.

How to get Mounjaro online through Zealthy

You answer health questions, a licensed provider reviews them, and our team deals with your insurer. A live call is optional.

Five steps, start to first dose
1. Join and complete the intake

Membership is $39 for the first month. The intake covers your health history, medications and goals. Say whether you have type 2 diabetes, because that decides which tirzepatide brand is on-label for you.

Hand holding a phone that shows a Zealthy intake question
2. A provider reads your intake

A U.S.-licensed physician or nurse practitioner reviews your intake online and decides whether a GLP-1 medication is appropriate, and which one. No live appointment is needed to start.

Phone screen showing a smiling provider in a white coat
3. We handle the prior authorization

For brand-name medication, our insurance coordination team submits the prior authorization. When your plan covers it, the copay can be as low as $25 a month. Approval is the plan’s decision.

Black and white portrait of a smiling woman with curly hair
4. Your prescription is filled

Brand-name prescriptions go to your own pharmacy. Compounded tirzepatide, if prescribed, ships from a partner pharmacy and usually arrives within 2 to 9 business days. It is not Mounjaro and not FDA-approved.

Black and white photo of two women laughing side by side
5. Stay in touch as your dose changes

Doses change no sooner than every four weeks. Message your care team about side effects at any time. A weight loss coach and optional video or phone visits are included.

Black and white portrait of a woman with blonde hair smiling over her shoulder
Woman with long curly hair laughing in front of a red wall

What your Zealthy membership pays for

  • A licensed provider’s review, and a prescription if one is appropriate
  • An insurance coordination team that files prior authorizations for brand-name medication
  • Unlimited secure messaging with your care team
  • Monthly video or phone visits with a provider, if you want them
  • A weight loss coach
  • The Zealthy app on iOS and Android, and the online portal
$39First month
$135/moEvery month after

Medication is not part of the membership and is paid for separately.

Get Started

Mounjaro side effects and how common they are

Nausea is the most common Mounjaro side effect, reported by 12% to 18% of adults in placebo-controlled trials, against 4% on placebo. Most side effects involve the stomach and gut.

Side effect5 mg10 mg15 mgPlacebo
Nausea12%15%18%4%
Diarrhea12%13%17%9%
Decreased appetite5%10%11%1%
Vomiting5%5%9%2%
Constipation6%6%7%1%
Indigestion8%8%5%3%
Abdominal pain6%5%5%4%

Adults reporting each reaction in two pooled placebo-controlled trials. These are the reactions the label lists at 5% or higher.2

Ways to ease side effects

  • Report symptoms early. The label never forces an increase, so your provider can hold your dose.
  • Drink fluids if you are vomiting or have diarrhea. Dehydration can harm the kidneys.11
  • On insulin or a sulfonylurea? Ask whether that dose should come down.
  • On birth control pills? Add backup contraception for the 4 weeks following your first dose and every increase.

Get medical help right away for

  • Severe stomach pain that will not go away, with or without vomiting
  • A swollen face, lips, tongue or throat, or difficulty breathing
  • Upper stomach pain with fever, yellow skin or eyes, or clay-colored stools
  • Sudden changes in your vision
  • A lump or swelling in the neck, or lasting hoarseness

How long Mounjaro side effects tend to last

Most nausea, vomiting and diarrhea in the trials happened while the dose was being raised, and became less frequent over time. Gut side effects led 3.0% to 6.6% of people to stop treatment, against 0.4% on placebo.2

Other side effects and low blood sugar

Injection site reactions affected 3.2% of people, against 0.4% on placebo. Burping, gas, reflux and bloating each showed up in roughly 3% of people or fewer. Mounjaro alone rarely caused low blood sugar. With basal insulin, 14% to 19% had a reading under 54 mg/dL, against 13% on placebo.2

Why Mounjaro’s rates look lower than Zepbound’s

Zepbound’s label reports nausea in 25% to 29% of adults, though the drug is identical.5 The figures come from different trials in different people, and the labels caution against comparing rates across trials.

Serious risks and who should not take Mounjaro

Mounjaro’s boxed warning concerns thyroid C-cell tumors. People whose own or family history includes medullary thyroid carcinoma should not take it. Neither should people with Multiple Endocrine Neoplasia syndrome type 2, or people with a past serious allergic reaction to tirzepatide. The label also warns about pancreatitis, kidney injury from dehydration, severe stomach problems, gallbladder disease and worsening diabetic eye disease.2

On November 9, 2026, the FDA said GLP-1 labels must add a warning about a possible increased risk of NAION, a rare cause of sudden vision loss.12 See the full safety information and our GLP-1 side effects guide.

Mounjaro doses and dosing schedule

Mounjaro dosing starts at 2.5 mg once a week. The dose can then go up in 2.5 mg steps, each after four weeks or more on the current dose, if more blood sugar control is needed. The maximum is 15 mg for adults and 10 mg for ages 10 to 17.

Weekly doseEarliest startNotes
2.5 mgWeek 1Starting dose for everyone.
5 mgWeek 5First step up, if needed.
7.5 mgWeek 9If more blood sugar control is needed.
10 mgWeek 13Top dose for patients under 18.
12.5 mgWeek 17For adults.
15 mgWeek 21Maximum for adults.
  1. 2.5 mgStarting dose
  2. 5 mgIf needed
  3. 7.5 mgIf needed
  4. 10 mgAges 10 to 17 maximum
  5. 12.5 mgIf needed
  6. 15 mgAdult maximum

Weeks show the fastest schedule the prescribing information allows.2 Many people stay longer on a dose or never reach 15 mg.

What changed in Mounjaro dosing in 2026

The label revised in August 2026 no longer moves everyone to 5 mg after four weeks. Increases now depend on blood sugar.2 Zepbound still requires the step to 5 mg.5 Mounjaro doses are not based on body weight and need no adjustment for kidney or liver impairment.

How to take Mounjaro

  • Weekly, at whatever time suits you, with a meal or without.
  • Inject under the skin of the abdomen or thigh. The back of the upper arm is for when someone else injects.
  • Rotate the site each week. Never mix it with insulin.2

If you miss a dose

  • Within 4 days (96 hours): take it as soon as you can.
  • After 4 days: skip it and resume on your usual day.
  • Keep at least 3 days (72 hours) between any two doses.11

Pens and storage

  • A single-dose pen holds one dose. A carton holds four.
  • Keep refrigerated (36°F to 46°F) inside the carton. Do not freeze.
  • A single-dose pen can stay at up to 86°F for 21 days in total.2

The label also lists single-dose vials, a four-dose vial and a four-dose KwikPen, which has its own 30-day storage rule. LillyDirect sells only the single-dose pen.13 For compounded vials, see tirzepatide dosing in units.

Prices checked November 2026

Mounjaro cost, savings card and coupon rules

Mounjaro can cost $25 a fill when a commercial plan covers it and you use Lilly’s savings card. Without coverage it starts at $499 a month. The list price is $1,112.16 per fill.

Your situationWhat you may payDetails
Commercial plan covers MounjaroAs little as $25 per fillWith the Mounjaro Savings Card and an on-label prescription.3
Commercial plan does not cover itAs low as $499 a monthSavings card price for an on-label prescription.3
No insuranceFrom $499 a monthLillyDirect self-pay price for the single-dose pen, any strength. Taxes and fees may apply.13
Medicare or MedicaidSet by your planNo savings card. By Lilly’s count, roughly 8 of every 10 Part D enrollees spend $0 to $50 per 28 days.3
List price$1,112.16 per fillLilly’s published price for four pens, as of November 2026.14

Lilly sets these prices and can change them. The current savings card expires December 31, 2026.

How much does Mounjaro cost with insurance?

With insurance you pay your plan’s copay, minus any savings card you qualify for. Plans have generally covered GLP-1 medications for diabetes.7 Many require a prior authorization, and Zealthy’s coordination team submits it. When your plan covers the medication, the copay can be as low as $25 a month.

How much does Mounjaro cost without insurance?

Without insurance, Mounjaro starts at $499 a month through LillyDirect, at every strength.13 You still need a prescription. If you are paying cash for weight management, compare Zepbound, whose self-pay prices start at $299.15

Mounjaro savings card: what it does

Eli Lilly runs the Mounjaro Savings Card. It is a copay card and the only manufacturer coupon for Mounjaro. There are two levels of savings, and yours turns on whether your commercial plan covers the drug.3

Card termsPlan covers MounjaroPlan does not cover it
Lowest price$25 per fill$499 per fill
Fill length28, 56 or 84 days28 days
Per-fill cap$150, $300 or $450$647
Fills allowed each year1313
Yearly cap$1,950$8,411
Card endsDec. 31, 2026Dec. 31, 2026

The card pays $150 at most toward a one-month fill. If your copay is $175 or less you pay $25. Above that, you pay the difference: a $250 copay leaves $100. A three-month fill can cost $25 in total, if your plan and pharmacy allow one.

Who can use the Mounjaro savings card

You must meet every condition at each fill.3

  • Your prescription is for the single-dose pen and for a use on Mounjaro’s label. All of those involve type 2 diabetes.
  • You have commercial drug insurance. The card does not work for people with no insurance.
  • You have no government coverage, such as Medicare, Medicaid, TRICARE, VA or a state drug program.
  • You are 18 or over and a U.S. or Puerto Rico resident.
  • You are not combining it with another coupon or discount card for Mounjaro.

To get one, select “Get Savings Card” on Lilly’s Mounjaro savings page, answer the eligibility questions and activate the card before your first fill.

Mounjaro with Medicare or Medicaid

The savings card cannot be used with government insurance, but coverage is a separate matter. Lilly says many Medicare Part D plans pay for Mounjaro when it treats type 2 diabetes.3 Medicaid programs must cover GLP-1 medications for diabetes.16 The Medicare GLP-1 Bridge is for weight management and does not include Mounjaro.17

What you pay through Zealthy

  • Membership: $39 the first month and $135 each month after. Medication is separate.
  • Brand Mounjaro or Zepbound through insurance: we submit the prior authorization. When your plan covers it, the copay can be as low as $25 a month at your own pharmacy.
  • Compounded tirzepatide: $329 a month, or from $216 a month on a 3-month supply, shipping included.

Compounded tirzepatide is not Mounjaro and is not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality, and says they should be used only when an approved drug cannot meet a patient’s needs.6 A Zealthy provider prescribes it only when appropriate for you.

Mounjaro for weight loss without diabetes? Coverage is unlikely and the savings card will not apply. Zepbound is the on-label choice. Check your plan with the GLP-1 insurance checker, or see tirzepatide near me.

LillyDirect and Mounjaro

LillyDirect fills Mounjaro prescriptions. It does not write them.

LillyDirect is Eli Lilly’s own pharmacy channel. It sells the Mounjaro single-dose pen for self-pay from $499 a month once a licensed provider sends in a prescription.13

FeatureZealthyLillyDirect
What it isTelehealth program with U.S.-licensed providersThe manufacturer’s pharmacy service
PrescribesYes, when a provider finds it appropriateNo. It needs a prescription from your provider
Insurance for MounjaroWe submit the prior authorization to your planListed as self-pay
Price of MounjaroYour plan’s copay, as low as $25/mo when coveredFrom $499/mo
Ongoing careMessaging, coaching and optional visitsStays with your own prescriber

LillyDirect details are from Lilly’s site as of November 2026. Zealthy is not affiliated with Eli Lilly or LillyDirect.

Get Started

Mounjaro vs Zepbound, Ozempic, Wegovy and compounded tirzepatide

Zepbound and Wegovy® are approved for weight management. Mounjaro and Ozempic are approved for type 2 diabetes. Compounded tirzepatide is not FDA-approved.

FeatureMounjaroZepboundOzempicWegovyCompounded tirzepatide
Active ingredientTirzepatideTirzepatideSemaglutideSemaglutideTirzepatide
Acts onGIP and GLP-1GIP and GLP-1GLP-1GLP-1GIP and GLP-1
FDA-approved forType 2 diabetes2Weight management, sleep apnea5Type 2 diabetes18Weight management19Not FDA-approved
Weekly dose range2.5 to 15 mg2.5 to 15 mg0.25 to 2 mg0.25 to 7.2 mgSet by your provider
Average weight loss in a key trial12.8% to 14.7% in 72 weeks, with diabetes415.0% to 20.9% in 72 weeks, without diabetes105.7 kg in 40 weeks at 1 mg, with diabetes814.9% in 68 weeks at 2.4 mg, without diabetes20Not studied in these trials
Maker’s self-pay priceFrom $499/mo13From $299/mo for the KwikPen15$349/mo, or $499/mo for the 2 mg pen21$349/mo for the pen up to 2.4 mg22Zealthy: $329/mo, or from $216/mo on a 3-month supply

Prices as of November 2026. Trial results come from separate studies and are not head-to-head comparisons. Results from brand-name trials should not be assumed for compounded tirzepatide, which is not FDA-approved.

Zealthy members

What Zealthy members say about their care

One of the things I appreciate most about semaglutide is its convenience. The once-weekly dosing schedule has made it incredibly easy to integrate into my routine. It's a relief to know that I don't have to worry about multiple daily injections or complicated medication schedules.
Michelle, 33 | Lost 48 pounds
I started semaglutide at the recommendation of my Zealthy provider and I'm so happy with that decision. I signed up for their weight loss program and they've been giving me everything I need to make better lifestyle choices to get results that last. And the program's super affordable. 10/10 I can't recommend this enough.
Michael, 37 | Lost 29 pounds
Getting support a weight loss program has always been hard for me. I had been wanting to start one with a medication component for a while and Zealthy was the first one that made it easy for me with weight loss shots sent to me. They made it SO affordable and the medical team is great.
Susanne, 60 | Lost 33 pounds
Since I started, I have already lost 35 pounds and feel so much better. My doctor also helped me get a prescription for ozempic and he is always available to answer my questions in the message portal. This made me feel a lot more comfortable and excited to lose weight.
Rachel | Zealthy Member
The weight loss program is fantastic. Everyone has been so helpful and has helped me feel much more excited about the process. I was nervous to see my weight loss treatment plan, since I have done programs in the past, but they always wanted me to make drastic changes. I mentioned all of this to my weight loss coach and she was very understanding and made a customized plan for me.
John | Zealthy Member
I've been a member for 6 months now and have received all my medication every 3 months. Everyone has been so helpful and my care team is always available to help me!
Sara | Zealthy Member

Individual results may vary. These are the experiences of Zealthy members and are not a guarantee of any outcome. Medication is prescribed only when a licensed provider finds it appropriate.

A Zealthy provider shown on a phone screen
Your care team

A licensed provider reads your history before any Mounjaro prescription

A U.S.-licensed physician or nurse practitioner checks your health history, including whether you have type 2 diabetes, before prescribing anything. If Mounjaro is the wrong medication for you, they will say so and explain the alternatives.

50 statesLicensed providers for members in every state
No appointment neededYour intake is reviewed online, and questions are handled by message
7 days a weekSupport Monday to Friday 9am to 6pm ET, weekends 12pm to 6pm ET

The medical information on this page is reviewed by the Zealthy care team against FDA prescribing information and published clinical trials. It is general education, not personal medical advice.

Mounjaro FAQs

Is Mounjaro approved for weight loss?

No. Its FDA approvals cover type 2 diabetes in adults and children 10 and older, plus lowering cardiovascular risk in adults with type 2 diabetes. A prescription for weight loss alone is off-label. Zepbound contains the same drug, tirzepatide, and is the version approved for weight management.

How much weight loss does Mounjaro cause?

It varies. In SURMOUNT-2, a 72-week trial in adults with type 2 diabetes, the average loss was 12.8% of body weight with tirzepatide 10 mg and 14.7% with 15 mg, against 3.2% with placebo. Mounjaro’s 40-week diabetes trials showed average losses of 5.4 to 11.2 kg. These are averages, not predictions.

What is the starting dose of Mounjaro?

The starting dose is 2.5 mg, injected once a week. When your blood sugar needs more help, the provider may increase it in 2.5 mg steps, once you have spent four weeks or more at your present dose. The dosing schedule shows the earliest week for each step.

What is the maximum Mounjaro dose?

Adults can go up to 15 mg weekly, and patients aged 10 to 17 stop at 10 mg weekly. Reaching 15 mg takes at least 20 weeks, because each 2.5 mg step lasts four weeks or longer. Many people never need the top dose.

I missed my Mounjaro injection. What now?

Inject it as soon as you can if no more than 4 days (96 hours) have passed since the missed dose. After 4 days, skip it and inject on your next regular day. Do not take two doses within 3 days (72 hours) of each other.

How much does Mounjaro cost without insurance?

Without insurance, Mounjaro starts at $499 a month through LillyDirect, Eli Lilly’s self-pay channel, for the single-dose pen at any strength. Lilly’s list price is $1,112.16 per fill of four pens. Both figures are as of November 2026, and a prescription is required either way.

What does the Mounjaro savings card take off the price?

Up to $150 for each month of medication. Eli Lilly issues it as a copay card. When commercial insurance covers Mounjaro, a fill of one, two or three months can drop to $25. Savings are capped at $1,950 a year and 13 fills, and the card ends on December 31, 2026.

Important safety information

A summary of Mounjaro’s labeling. It does not replace the full prescribing information.

Boxed warning: risk of thyroid C-cell tumors

In rat studies, tirzepatide led to thyroid C-cell tumors. Nobody knows yet whether Mounjaro does the same in people, including a cancer called medullary thyroid carcinoma (MTC). Mounjaro is off limits if MTC has ever occurred in you or your family, and for people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Let your provider know right away about a neck lump or swelling, difficulty swallowing, breathlessness or hoarseness that lingers.2

Do not take Mounjaro if

  • You or a close relative has ever had MTC, or you have MEN 2.
  • Tirzepatide, or anything else in the product, has given you a serious allergic reaction.

Tell your provider before you start if you

  • Have or have had pancreas problems.
  • Have severe stomach problems, such as gastroparesis.
  • Have a history of diabetic retinopathy.
  • Are pregnant, breastfeeding, or planning either.
  • Have surgery or another procedure coming up that uses anesthesia or deep sedation.
  • Take insulin, a sulfonylurea or birth control pills.11

Sources

  1. U.S. Food and Drug Administration. FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes. May 13, 2022. https://content.govdelivery.com/accounts/USFDA/bulletins/317b871
  2. Mounjaro (tirzepatide) Prescribing Information. Eli Lilly and Company. Revised 08/2026. https://pi.lilly.com/us/mounjaro-uspi.pdf
  3. Eli Lilly and Company. Mounjaro savings and support, with Savings Card terms. https://mounjaro.lilly.com/savings-resources
  4. Garvey WT, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2). Lancet. 2023;402(10402):613-626. https://pubmed.ncbi.nlm.nih.gov/37385275/
  5. Zepbound (tirzepatide) Prescribing Information. Eli Lilly and Company. Revised 08/2026. https://pi.lilly.com/us/zepbound-uspi.pdf
  6. U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  7. KFF. 2026 Employer Health Benefits Survey. https://www.kff.org/health-costs/2026-employer-health-benefits-survey/
  8. Frías JP, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2). N Engl J Med. 2021;385(6):503-515. https://pubmed.ncbi.nlm.nih.gov/34170647/
  9. Nicholls SJ, et al. Cardiovascular outcomes with tirzepatide versus dulaglutide in type 2 diabetes (SURPASS-CVOT). N Engl J Med. 2025;393(24):2409-2420. https://pubmed.ncbi.nlm.nih.gov/41406444/
  10. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/
  11. Mounjaro (tirzepatide) Medication Guide. Eli Lilly and Company. Revised August 2026. https://pi.lilly.com/us/mounjaro-us-mg.pdf
  12. U.S. Food and Drug Administration. FDA Requires Safety Labeling Changes for GLP-1 Receptor Agonists Due to Potential Increased Risk of Rare But Serious Eye Condition. November 9, 2026. https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential
  13. Eli Lilly and Company. Mounjaro through LillyDirect. https://www.lilly.com/lillydirect/medicines/mounjaro
  14. Eli Lilly and Company. Mounjaro list price. https://pricinginfo.lilly.com/mounjaro
  15. Eli Lilly and Company. Zepbound through LillyDirect. https://www.lilly.com/lillydirect/zepbound
  16. KFF. Medicaid Coverage of and Spending on GLP-1s. https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/
  17. Medicare.gov. Weight loss drugs (Medicare GLP-1 Bridge). https://www.medicare.gov/glp1bridge
  18. Ozempic (semaglutide) Prescribing Information. Novo Nordisk. Revised 05/2026. https://www.novo-pi.com/ozempic.pdf
  19. Wegovy (semaglutide) Prescribing Information. Novo Nordisk. Revised 06/2026. https://www.novo-pi.com/wegovy.pdf
  20. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
  21. Novo Nordisk. Ozempic cost and savings. https://www.ozempic.com/savings-and-resources/save-on-ozempic.html
  22. Novo Nordisk. Wegovy cost and savings (NovoCare). https://www.novocare.com/obesity/products/wegovy/let-us-help/explaining-list-price.html

Web sources accessed November 18, 2026. Reviewed by the Zealthy care team.

Find out whether Mounjaro is the right fit

Complete the online intake and a licensed provider will review it. Your first month of membership is $39, and medication is separate.

Get Started